Daniel J. O'Connor - 01 Jun 2022 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role: Director
Signature: /s/ Michael Golembiewski, as attorney-in-fact for Daniel J. O'Connor
Issuer symbol: N/A
Transactions as of: 01 Jun 2022
Net transactions value: +$9,789
Form type: 4
Filing time: 02 Jun 2022, 16:29:45 UTC
Previous filing: 10 Mar 2022
Next filing: 14 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SEEL	Common Stock	Purchase	$9,789	+16,000		$0.6118	16,000	01 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.6054 per share to $0.6127 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Content

The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.6054 per share to $0.6127 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Remarks:

Exhibit 24 - Power of Attorney